@article{1d15ba0bdf8049e8bbe5067d5f3c9c0e,
title = "Targeting Sleep and Circadian Function in the Prevention of Alzheimer Disease",
abstract = "Agrowingbodyof evidence supports the association between sleep and circadian function and AD risk. A tsunami of AD looms in the coming 20 to 30 years, and sleep and circadian therapies that reduce AD risk would benefit societal health. To achieve such a goal,researchers in this area must intentionally adopt strategies to translate science efficiently and collaboratively into clinical trials and public implementation.",
author = "Musiek, {Erik S.} and Ju, {Yo El S.}",
note = "Funding Information: reported receiving grants from NIH for circadian rhythms research during the conduct of the study, grants from Eisai Pharmaceuticals for animal research pertaining to sleep, and grants from Centene Corporation for basic research related to circadian rhythms outside the submitted work. Dr Ju reported receiving grants from NIH RF1AG061776, grants from Centene Corporation contract (P19-00559) for the Washington University-Centene ARCH Personalized Medicine Initiative, and personal fees from Applied Cognition consultancy outside the submitted work. No other disclosures were reported.",
year = "2022",
month = sep,
doi = "10.1001/jamaneurol.2022.1732",
language = "English",
volume = "79",
pages = "835--836",
journal = "JAMA Neurology",
issn = "2168-6149",
number = "9",
}